Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 34

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Inhibition of Erythromycin and Erythromycin-Induced Resistance among Staphylococcus aureus Clinical Isolates

Mahfouz, Aya A., Said, Heba S., Elfeky, Sherin M., Shaaban, Mona I.·2023·Antibiotics

Abstract

The increasing incidence of erythromycin and erythromycin-induced resistance to clindamycin among Staphylococcus aureus (S. aureus) is a serious problem. Patients infected with inducible resistance phenotypes may fail to respond to clindamycin. This study aimed to identify the prevalence of erythromycin and erythromycin-induced resistance and assess for potential inhibitors. A total of 99 isolates were purified from various clinical sources. Phenotypic detection of macrolide-lincosamide-streptogramin B (MLSB)-resistance phenotypes was performed by D-test. MLSB-resistance genes were identified using PCR. Different compounds were tested for their effects on erythromycin and inducible clindamycin resistance by broth microdilution and checkerboard microdilution methods. The obtained data were evaluated using docking analysis. Ninety-one isolates were S. aureus. The prevalence of constitutive MLSB, inducible MLSB, and macrolide-streptogramin (MS) phenotypes was 39.6%, 14.3%, and 2.2%, respectively. Genes including ermC, ermA, ermB, msrA, msrB, lnuA, and mphC were found in 82.6%, 5.8%, 7.7%, 3.8%, 3.8%, 13.5%, and 3.8% of isolates, respectively. Erythromycin resistance was significantly reduced by doxorubicin, neomycin, and omeprazole. Quinine, ketoprofen, and fosfomycin combated and reversed erythromycin/clindamycin-induced resistance. This study highlighted the significance of managing antibiotic resistance and overcoming clindamycin treatment failure. Doxorubicin, neomycin, omeprazole, quinine, ketoprofen, and fosfomycin could be potential inhibitors of erythromycin and inducible clindamycin resistance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/antibiotics12030503

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 104

  1. Bitrus, 2018, Staphylococcus aureus: A review of antimicrobial resistance mechanisms, Vet. Sci. Res. J., 4, 43
  2. Fetsch, A. (2018). Staphylococcus Aureus, Elsevier. [1st ed.].
  3. Che Hamzah, A.M., Yeo, C.C., Puah, S.M., Chua, K.H., and Chew, C.H. (2019). Staphylococcus aureus infections in Malaysia: A review of antimicrobial resistance and characteristics of the clinical isolates, 1990–2017. Antibiotics, 8. · DOI
  4. Connolly, 2017, Identification of Staphylococcus aureus factors required for pathogenicity and growth in human blood, Infect. Immun., 85, e00337-17, 10.1128/IAI.00337-17 · DOI
  5. Schönfeld, W., and Kirst, H.A. (2002). Macrolide Antibiotics, Springer Science & Business Media. · doi:10.1007/978-3-0348-8105-0
  6. Roberts, 1999, Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants, Antimicrob. Agents Chemother., 43, 2823, 10.1128/AAC.43.12.2823 · DOI · Paper page
  7. Aktas, 2007, Resistance to macrolide, lincosamide and streptogramin antibiotics in staphylococci isolated in Istanbul, Turkey, J. Microbiol., 45, 286
  8. Reynolds, 2003, Msr (A) and related macrolide/streptogramin resistance determinants: Incomplete transporters?, Int. J. Antimicrob. Agents, 22, 228, 10.1016/S0924-8579(03)00218-8 · DOI
  9. Luna, 1999, A variety of gram-positive bacteria carry mobile mef genes, J. Antimicrob. Chemother., 44, 19, 10.1093/jac/44.1.19 · DOI · Paper page
  10. Matsuoka, 2003, Characteristic expression of three genes, msr (A), mph (C) and erm (Y), that confer resistance to macrolide antibiotics on Staphylococcus aureus, FEMS Microbiol. Lett., 220, 287, 10.1016/S0378-1097(03)00134-4 · DOI
  11. Zelazny, 2005, Selection of strains for quality assessment of the disk induction method for detection of inducible clindamycin resistance in staphylococci: A CLSI collaborative study, J. Clin. Microbiol., 43, 2613, 10.1128/JCM.43.6.2613-2615.2005 · doi:10.1128/jcm.43.6.2613-2615.2005
  12. Leclercq, 2002, Mechanisms of resistance to macrolides and lincosamides: Nature of the resistance elements and their clinical implications, Clin. Infect. Dis., 34, 482, 10.1086/324626 · DOI · Paper page
  13. Saribas, 2006, Prevalence of erm genes encoding macrolide-lincosamide-streptogramin (MLS) resistance among clinical isolates of Staphylococcus aureus in a Turkish university hospital, Clin. Microbiol. Infect., 12, 797, 10.1111/j.1469-0691.2006.01486.x · doi:10.1111/j.1469-0691.2006.01486.x
  14. Lina, 1999, Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci, Antimicrob. Agents Chemother., 43, 1062, 10.1128/AAC.43.5.1062 · DOI · Paper page
  15. Ounissi, 1985, Nucleotide sequence of the gene ereA encoding the erythromycin esterase in Escherichia coli, Gene, 35, 271, 10.1016/0378-1119(85)90005-8 · DOI
  16. Chesneau, 2007, Resistance phenotypes conferred by macrolide phosphotransferases, FEMS Microbiol. Lett., 269, 317, 10.1111/j.1574-6968.2007.00643.x · DOI
  17. Delrieu, 1988, Inactivation of lincosaminide antibiotics in Staphylococcus. Identification of lincosaminide O-nucleotidyltransferases and comparison of the corresponding resistance genes, J. Biol. Chem., 263, 15880, 10.1016/S0021-9258(18)37532-X · DOI
  18. Allignet, 1999, Comparative analysis of staphylococcal plasmids carrying three streptogramin-resistance genes: vat–vgb–vga, Plasmid, 42, 134, 10.1006/plas.1999.1412 · DOI
  19. Daurel, 2008, Differences in potential for selection of clindamycin-resistant mutants between inducible erm (A) and erm (C) Staphylococcus aureus genes, J. Clin. Microbiol., 46, 546, 10.1128/JCM.01925-07 · doi:10.1128/jcm.01925-07
  20. Drinkovic, 2001, Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance, J. Antimicrob. Chemother., 48, 315, 10.1093/jac/48.2.315 · DOI · Paper page
  21. Siberry, 2003, Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro, Clin. Infect. Dis., 37, 1257, 10.1086/377501 · DOI · Paper page
  22. Gould, 2009, Antibiotic resistance: The perfect storm, Int. J. Antimicrob. Agents, 34, S2, 10.1016/S0924-8579(09)70549-7 · doi:10.1016/s0924-8579(09)70549-7
  23. Clancy, 1995, Assays to detect and characterize synthetic agents that inhibit the ErmC methyltransferase, J. Antibiot., 48, 1273, 10.7164/antibiotics.48.1273 · doi:10.7164/antibiotics.48.1273
  24. Ahirrao, 2020, MsrA efflux pump inhibitory activity of Piper cubeba lf and its phytoconstituents against Staphylococcus aureus RN4220, Chem. Biodivers., 17, e2000144, 10.1002/cbdv.202000144 · DOI
  25. Figueredo, 2021, Inhibition of Staphylococcus aureus TetK and MsrA efflux pumps by hydroxyamines derived from lapachol and norlachol, J. Bioenerg. Biomembr., 53, 149, 10.1007/s10863-021-09885-5 · DOI
  26. Smith, 2007, The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus, Antimicrob. Agents Chemother., 51, 4480, 10.1128/AAC.00216-07 · DOI
  27. Fung, 2017, Synergists from Portulaca oleracea with macrolides against methicillin-resistant Staphylococcus aureus and related mechanism, Hong Kong Med. J., 23, 38
  28. Kaatz, 1993, Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus, Antimicrob. Agents Chemother., 37, 1086, 10.1128/AAC.37.5.1086 · DOI · Paper page
  29. Saber, 2018, The inhibitory effect of fluphenazinedecanoate and caffeine on Staphylococcus aureus efflux pumps, Curr. Res. Microbiol. Biotechnol., 6, 1530
  30. Kumar, 2008, Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus, J. Antimicrob. Chemother., 61, 1270, 10.1093/jac/dkn088 · DOI · Paper page
  31. Vidaillac, 2007, Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus, Antimicrob. Agents Chemother., 51, 831, 10.1128/AAC.01306-05 · DOI
  32. Tintino, 2016, Action of cholecalciferol and alpha-tocopherol on Staphylococcus aureus efflux pumps, EXCLI J., 15, 315
  33. Tintino, 2018, Vitamin K enhances the effect of antibiotics inhibiting the efflux pumps of Staphylococcus aureus strains, Med. Chem. Res., 27, 261, 10.1007/s00044-017-2063-y · DOI
  34. Aeschlimann, 1999, Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus, Antimicrob. Agents Chemother., 43, 335, 10.1128/AAC.43.2.335 · doi:10.1128/aac.43.2.335
  35. Bharate, 2015, Discovery of 4-acetyl-3-(4-fluorophenyl)-1-(p-tolyl)-5-methylpyrrole as a dual inhibitor of human P-glycoprotein and Staphylococcus aureus Nor A efflux pump, Org. Biomol. Chem., 13, 5424, 10.1039/C5OB00246J · DOI
  36. Blanchard, 2016, Neomycin sulfate improves the antimicrobial activity of mupirocin-based antibacterial ointments, Antimicrob. Agents Chemother., 60, 862, 10.1128/AAC.02083-15 · DOI
  37. Rumynska, 2021, Microbial biofilms and some aspects of anti-inflammatory drug use, Biopolym. Cell, 37, 247, 10.7124/bc.000A57 · DOI
  38. Khalaf, 2015, Antibacterial, anti-biofilm activity of some non-steroidal anti-inflammatory drugs and N-acetyl cysteine against some biofilm producing uropathogens, Am. J. Epidemiol., 3, 1
  39. Oselin, 2007, Inhibition of human thiopurine S-methyltransferase by various nonsteroidal anti-inflammatory drugs in vitro: A mechanism for possible drug interactions, Drug Metab. Dispos., 35, 1452, 10.1124/dmd.107.016287 · doi:10.1124/dmd.107.016287
  40. Abreu, 2016, Combinatorial approaches with selected phytochemicals to increase antibiotic efficacy against Staphylococcus aureus biofilms, Biofouling, 32, 1103, 10.1080/08927014.2016.1232402 · DOI
  41. Olateju, 2021, Quinoline antimalarials increase the antibacterial activity of ampicillin, Front. Microbiol., 12, 556550, 10.3389/fmicb.2021.556550 · DOI
  42. Bodet, 1985, Antibacterial activities of antineoplastic agents, Antimicrob. Agents Chemother., 28, 437, 10.1128/AAC.28.3.437 · DOI
  43. Peiris, 1993, Antimicrobial activity of cytotoxic drugs may influence isolation of bacteria and fungi from blood cultures, J. Clin. Pathol., 46, 1124, 10.1136/jcp.46.12.1124 · DOI
  44. Gieringer, 1986, Effect of 5-fluorouracil, mitoxantrone, methotrexate, and vincristine on the antibacterial activity of ceftriaxone, ceftazidime, cefotiam, piperacillin, and netilmicin, Chemotherapy, 32, 418, 10.1159/000238445 · doi:10.1159/000238445
  45. Yokochi, 2004, Doxorubicin inhibits DNMT1, resulting in conditional apoptosis, Mol. Pharmacol., 66, 1415, 10.1124/mol.104.002634 · doi:10.1124/mol.104.002634
  46. Schlievert, 2021, Staphylococcal Enterotoxin C Subtypes Are Differentially Associated with Human Infections and Immunobiological Activities, mSphere, 6, e01153-20, 10.1128/mSphere.01153-20 · doi:10.1128/msphere.01153-20
  47. Mehraj, 2016, Epidemiology of Staphylococcus aureus nasal carriage patterns in the community, Curr. Top. Microbiol. Immunol., 398, 55
  48. Kuehl, 2020, When antibiotics fail: A clinical and microbiological perspective on antibiotic tolerance and persistence of Staphylococcus aureus, J. Antimicrob. Chemother., 75, 1071, 10.1093/jac/dkz559 · DOI
  49. Razeghi, 2019, Incidence of inducible clindamycin resistance and antibacterial resistance genes variability in clinical Staphylococcus aureus strains: A two-year multicenter study in Tehran, Iran, Gene Rep., 16, 100411, 10.1016/j.genrep.2019.100411 · DOI
  50. Ahmed, 2011, Nosocomial vancomycin and methicillin resistant staphylococcal infections in intensive care units in Assiut University Hospitals, Egypt. J. Med. Microbiol., 20, 127
  51. Isturiz, 2009, Epidemiology of meticillin-resistant Staphylococcus aureus (MRSA) in Latin America, Int. J. Antimicrob. Agents, 34, 304, 10.1016/j.ijantimicag.2009.06.005 · DOI
  52. Jiménez Quiceno, J.N., Ocampo Ríos, A.M., Vanegas Múnera, J.M., Rodríguez Tamayo, E.A., Mediavilla, J., Chen, L., Muskus, C., Vélez, L., Rojas, C., and Restrepo Gouzy, A. (2012). CC8 MRSA strains harboring SCCmec Type IVc are predominant in Colombian hospitals. PLoS ONE, 7. · DOI
  53. Youssef, 2021, The alarming association between antibiotic resistance and reduced susceptibility to biocides in nosocomial MRSA isolates from two regional hospitals in Egypt, Arch. Microbiol., 203, 3295, 10.1007/s00203-021-02314-6 · doi:10.1007/s00203-021-02314-6
  54. Kishk, 2020, Inducible clindamycin resistance in clinical isolates of staphylococcus aureus in Suez Canal University Hospital, Ismailia, Egypt, J. Infect. Dev. Ctries., 14, 1281, 10.3855/jidc.12250 · doi:10.3855/jidc.12250
  55. Adhikari, R., Shrestha, S., Barakoti, A., and Amatya, R. (2017). Inducible clindamycin and methicillin resistant Staphylococcus aureus in a tertiary care hospital, Kathmandu, Nepal. BMC Infect. Dis., 17. · DOI
  56. Majhi, 2016, Detection of inducible and constitutive clindamycin resistance among Staphylococcus aureus isolates in a tertiary care hospital, Eastern India, Avicenna J. Med., 6, 75, 10.4103/2231-0770.184066 · doi:10.4103/2231-0770.184066
  57. Hamzah, 2019, Tigecycline and inducible clindamycin resistance in clinical isolates of methicillin-resistant Staphylococcus aureus from Terengganu, Malaysia, J. Med. Microbiol., 68, 1299, 10.1099/jmm.0.000993 · DOI
  58. Jarajreh, 2017, Prevalence of inducible clindamycin resistance in methicillin-resistant Staphylococcus aureus: The first study in Jordan, J. Infect. Dev. Ctries., 11, 350, 10.3855/jidc.8316 · doi:10.3855/jidc.8316
  59. Sarrou, 2019, MLSB-resistant Staphylococcus aureus in central Greece: Rate of resistance and molecular characterization, Microb. Drug Resist., 25, 543, 10.1089/mdr.2018.0259 · doi:10.1089/mdr.2018.0259
  60. Mama, 2019, Methicillin-and inducible clindamycin-resistant Staphylococcus aureus among patients with wound infection attending Arba Minch Hospital, South Ethiopia, Int. J. Microbiol., 2019, 2965490, 10.1155/2019/2965490 · doi:10.1155/2019/2965490
  61. Maravic, 2004, Macrolide resistance based on the Erm-mediated rRNA methylation, Curr. Drug Targets Infect. Disord., 4, 193, 10.2174/1568005043340777 · DOI
  62. Elkammoshi, 2016, A low prevalence of inducible macrolide, lincosamide, and streptogramin b resistance phenotype among methicillin-susceptible Staphylococcus aureus isolated from malaysian patients and healthy individuals, Jundishapur J. Microbiol., 9, e37148
  63. Pereira, 2016, Phenotypic and molecular characterization of resistance to macrolides, lincosamides and type B streptogramin of clinical isolates of Staphylococcus spp. of a university hospital in Recife, Pernambuco, Brazil, Braz. J. Infect. Dis., 20, 276, 10.1016/j.bjid.2016.03.003 · DOI
  64. Cabrera, 2020, Molecular characterization of methicillin-resistant Staphylococcus aureus clinical strains from the endotracheal tubes of patients with nosocomial pneumonia, Antimicrob. Resist. Infect. Control, 9, 43, 10.1186/s13756-020-0679-z · DOI
  65. Schwarz, 2006, Antimicrobial resistance of coagulase-negative staphylococci from bovine subclinical mastitis with particular reference to macrolide–lincosamide resistance phenotypes and genotypes, J. Antimicrob. Chemother., 57, 966, 10.1093/jac/dkl061 · DOI · Paper page
  66. Phaku, 2016, Unveiling the molecular basis of antimicrobial resistance in Staphylococcus aureus from the Democratic Republic of the Congo using whole genome sequencing, Clin. Microbiol. Infect., 22, 644.e1, 10.1016/j.cmi.2016.04.009 · DOI
  67. Akpaka, 2017, Molecular characterization of antimicrobial resistance genes against Staphylococcus aureus isolates from Trinidad and Tobago, J. Infect. Public Health, 10, 316, 10.1016/j.jiph.2016.05.010 · DOI
  68. Osman, 2015, Characterization of resistance genes to macrolides, lincosamides and streptogramins (MLS) among clinical isolates of Staphylococcus aureus in North Lebanon, Int. Arab. J. Antimicrob. Agents, 5, 3
  69. Schwarz, 2007, Molecular basis of resistance to macrolides and lincosamides among staphylococci and streptococci from various animal sources collected in the resistance monitoring program BfT-GermVet, Int. J. Antimicrob. Agents, 29, 528, 10.1016/j.ijantimicag.2006.12.016 · DOI
  70. Schwarz, 2016, Lincosamides, streptogramins, phenicols, and pleuromutilins: Mode of action and mechanisms of resistance, Cold Spring Harb. Perspect. Med., 6, a027037, 10.1101/cshperspect.a027037 · DOI
  71. Liang, 2019, Antimicrobial resistance, virulence genes profiling and molecular relatedness of methicillin-resistant Staphylococcus aureus strains isolated from hospitalized patients in Guangdong Province, China, Infect. Drug Resist., 12, 447, 10.2147/IDR.S192611 · doi:10.2147/idr.s192611
  72. Ceballos, S., Lozano, C., Aspiroz, C., Ruiz-Ripa, L., Eguizábal, P., Campaña-Burguet, A., Cercenado, E., López-Calleja, A.I., Castillo, J., and Azcona-Gutiérrez, J.M. (2022). Beyond CC398: Characterisation of Other Tetracycline and Methicillin-Resistant Staphylococcus aureus Genetic Lineages Circulating in Spanish Hospitals. Pathogens, 11. · DOI
  73. Yebra, 1991, The effect of sinefungin and synthetic analogues on RNA and DNA methyltransferases from Streptomyces, J. Antibiot., 44, 1141, 10.7164/antibiotics.44.1141 · doi:10.7164/antibiotics.44.1141
  74. Miranda, 2009, DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation, Mol. Cancer Ther., 8, 1579, 10.1158/1535-7163.MCT-09-0013 · DOI · Paper page
  75. Barbes, 1990, Effects of sinefungin and S-adenosylhomocysteine on DNA and protein methyltransferases from Streptomyces and other bacteria, FEMS Microbiol. Lett., 69, 239, 10.1111/j.1574-6968.1990.tb04237.x · doi:10.1111/j.1574-6968.1990.tb04237.x
  76. Schluckebier, 1999, The 2.2 Å structure of the rRNA methyltransferase ErmC′ and its complexes with cofactor and cofactor analogs: Implications for the reaction mechanism, J. Mol. Biol., 289, 277, 10.1006/jmbi.1999.2788 · DOI
  77. Svetlov, 2021, Structure of Erm-modified 70S ribosome reveals the mechanism of macrolide resistance, Nat. Chem. Biol., 17, 412, 10.1038/s41589-020-00715-0 · DOI
  78. Dunkle, 2010, Structures of the Escherichia coli ribosome with antibiotics bound near the peptidyl transferase center explain spectra of drug action, Proc. Natl. Acad. Sci. USA, 107, 17152, 10.1073/pnas.1007988107 · DOI · Paper page
  79. Lando, 1976, Paromomycin and dihydrostreptomycin binding to Escherichia coli ribosomes, Eur. J. Biochem., 66, 597, 10.1111/j.1432-1033.1976.tb10587.x · DOI
  80. Kleinzeller, A., Springer, G.F., and Wittmann, H.G. (1979). Inhibitors of Protein Biosynthesis, Springer. [30th ed.].
  81. Dahlberg, 1978, Interaction of neomycin with ribosomes and ribosomal ribonucleic acid, Antimicrob. Agents Chemother., 13, 331, 10.1128/AAC.13.2.331 · doi:10.1128/aac.13.2.331
  82. Sharkey, 2016, ABC-F proteins mediate antibiotic resistance through ribosomal protection, MBio, 7, e01975–e15, 10.1128/mBio.01975-15 · DOI · Paper page
  83. Gibbons, 2003, A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus, J. Antimicrob. Chemother., 51, 13, 10.1093/jac/dkg044 · DOI · Paper page
  84. Gibbons, 2004, Anti-staphylococcal plant natural products, Nat. Prod. Rep., 21, 263, 10.1039/b212695h · DOI · Paper page
  85. Maton, 1991, Omeprazole, N. Engl. J. Med., 324, 965, 10.1056/NEJM199104043241406 · doi:10.1056/nejm199104043241406
  86. 2004, Lincomycin, clindamycin and their applications, Appl. Microbiol. Biotechnol., 64, 455, 10.1007/s00253-003-1545-7 · DOI · Paper page
  87. Lee, H.J., Jhang, S.T., and Jin, H.J. (2021). Potential Target Site for Inhibitors in MLSB Antibiotic Resistance. Antibiotics, 10. · doi:10.3390/antibiotics10030264
  88. Steward, 2005, Testing for induction of clindamycin resistance in erythromycin-resistant isolates of Staphylococcus aureus, J. Clin. Microbiol., 43, 1716, 10.1128/JCM.43.4.1716-1721.2005 · DOI · Paper page
  89. Williams, 1990, DNA polymorphisms amplified by arbitrary primers are useful as genetic markers, Nucleic Acids Res., 18, 6531, 10.1093/nar/18.22.6531 · DOI · Paper page
  90. Tintino, 2017, Tannic acid affects the phenotype of Staphylococcus aureus resistant to tetracycline and erythromycin by inhibition of efflux pumps, Bioorg. Chem., 74, 197, 10.1016/j.bioorg.2017.08.004 · DOI
  91. Cetin, 2013, Determination of in vitro activities of polymyxin B and rifampin in combination with ampicillin/sulbactam or cefoperazone/sulbactam against multidrug-resistant Acinetobacter baumannii by the E-test and checkerboard methods, Jpn. J. Infect. Dis., 66, 463, 10.7883/yoken.66.463 · DOI
  92. Hsieh, 1993, Synergy assessed by checkerboard a critical analysis, Diagn. Microbiol. Infect. Dis., 16, 343, 10.1016/0732-8893(93)90087-N · DOI · Paper page
  93. EUCAST (2000). Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents. Clin. Microbiol. Infect., 6, 503–508. · DOI · Paper page
  94. Vilar, 2008, Medicinal chemistry and the molecular operating environment (MOE): Application of QSAR and molecular docking to drug discovery, Curr. Top. Med. Chem., 8, 1555, 10.2174/156802608786786624 · DOI · Paper page
  95. Matsuoka, 1998, A plasmid that encodes three genes for resistance to macrolide antibiotics in Staphylococcus aureus, FEMS Microbiol. Lett., 167, 221, 10.1111/j.1574-6968.1998.tb13232.x · DOI
  96. Strommenger, 2003, Multiplex PCR assay for simultaneous detection of nine clinically relevant antibiotic resistance genes in Staphylococcus aureus, J. Clin. Microbiol., 41, 4089, 10.1128/JCM.41.9.4089-4094.2003 · DOI · Paper page
  97. Leclercq, 1989, Selection of constitutive mutants of gram-positive cocci inducible resistant to macrolides, lincosamides and streptogramins (MLS): Comparison of the selective effects of the MLS, Pathol. Biol., 37, 568
  98. Ross, 1990, Inducible erythromycin resistance in staphlyococci is encoded by a member of the ATP-binding transport super-gene family, Mol. Microbiol., 4, 1207, 10.1111/j.1365-2958.1990.tb00696.x · DOI · Paper page
  99. Bozdogan, 1999, A new resistance gene, linB, conferring resistance to lincosamides by nucleotidylation in Enterococcus faecium HM1025, Antimicrob. Agents Chemother., 43, 925, 10.1128/AAC.43.4.925 · DOI · Paper page
  100. Sutcliffe, 1996, Detection of erythromycin-resistant determinants by PCR, Antimicrob. Agents Chemother., 40, 2562, 10.1128/AAC.40.11.2562 · DOI · Paper page
  101. Allignet, 1992, Sequence of a staphylococcal plasmid gene, vga, encoding a putative ATP-binding protein involved in resistance to virginiamycin A-like antibiotics, Gene, 117, 45, 10.1016/0378-1119(92)90488-B · DOI
  102. Loncle, 1993, Analysis of pristinamycin-resistant Staphylococcus epidermidis isolates responsible for an outbreak in a Parisian hospital, Antimicrob. Agents Chemother., 37, 2159, 10.1128/AAC.37.10.2159 · doi:10.1128/aac.37.10.2159
  103. Hammerum, 1998, Detection of the satA gene and transferability of virginiamycin resistance in Enterococcus faecium from food-animals, FEMS Microbiol. Lett., 168, 145, 10.1111/j.1574-6968.1998.tb13267.x · DOI
  104. Allignet, 1998, Characterization of a staphylococcal plasmid related to pUB110 and carrying two novel genes, vatC and vgbB, encoding resistance to streptogramins A and B and similar antibiotics, Antimicrob. Agents Chemother., 42, 1794, 10.1128/AAC.42.7.1794 · DOI

Cited by

See all 34

Metadata

Authors
Mahfouz, A. A., Said, H. S., Elfeky, S. M., & Shaaban, M. I.
Venue
Antibiotics
Publisher
MDPI AG
Published
2023-03-02
Volume
12
Issue
3
Pages
503
ISSN
2079-6382
Cited by
34
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhibition of Erythromycin and Erythromycin-Induced Resistance among Staphylococcus aureus Clinical Isolates. https://app.cochat.ai/papers/10.3390/antibiotics12030503
The paper
Mahfouz, A. A., Said, H. S., Elfeky, S. M., & Shaaban, M. I. (2023). Inhibition of Erythromycin and Erythromycin-Induced Resistance among Staphylococcus aureus Clinical Isolates. Antibiotics. https://doi.org/10.3390/antibiotics12030503

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.